The living rapid reviews are led by researchers at the [Knowledge Synthesis and Application Unit][1] at the [University of Ottawa School of Epidemiology and Public Health][2]. The evidence will be used by members of the Rapid Testing Expert Advisory Group, Ireland. This research was funded by the Health Research Board through Evidence Synthesis Ireland [HRB Grant Number CBES-2018-001]. The living rapid reviews were also funded by The Strategy for Patient-Oriented Research Evidence Alliance (SPOR EA) which is supported by the Canadian Institutes of Health Research (CIHR) under the Strategy for Patient-Oriented Research (SPOR) initiative. ---------- Rapid antigen testing (KQ1) - [PROSPERO CRD42021284168][3] - [NCCMT Repository][5] Transmission risk, activities/settings (KQ2/KQ3) - [PROSPERO CRD42021284107][4] - [NCCMT Repository][6] Final review publication: TBA Associated publication: [Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021][7] [1]: https://med.uottawa.ca/epidemiology/research [2]: https://med.uottawa.ca/epidemiology/ [3]: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=284168 [4]: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=284107 [5]: https://www.nccmt.ca/covid-19/covid-19-evidence-reviews/471 [6]: https://www.nccmt.ca/covid-19/covid-19-evidence-reviews/472 [7]: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.3.2101202